AMAlessandro Macchia

Alessandro Macchia

*This is an algorithmically generated author record based on publicly available information.

Alessandro Macchia has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mathematical Model to Assess Mutational Burden in Retinal Dystrophy Patients Negative to Mendelian Genetic Tests and Carriers of Multiple Recessive Variants

    by Maria Chiara Medori, Alessandro Macchia, Paolo Enrico Maltese, Jan Miertuš, Francesca Cristofoli, Ornela Gordani, Xhilda Dhamo, Eglantina Kalluci, Dominika Vešelényiová, Stanislav Miertuš, et al.

    Purpose: Despite advancements in genetic testing, a significant number of patients with retinal dystrophy receive negative test results due to single-allele mutations in genes with autosomal recessive inheritance patterns. This study aimed to address this diagnostic challenge by proposing a preliminary mathematical model based on mutational burden analysis. This approach can identify unique digenic or oligogenic combinations, potentially prioritizing them for further investigation. Methods: We retrospectively analyzed clinical and genetic data from 527 subjects comprising 453 patients with retinal dystrophies (cases) and 74 controls and created semi-synthetic datasets. Protein– protein interaction networks were analyzed, and the significance of mutational burden in specific molecular pathways was investigated. Results: Our model identified two metabolic pathways that are highly correlated to each other, namely “retinoid cycle disease events” and “canonical retinoid cycle in rods (twilight vision).” These pathways were significantly impacted by the burden of variants we found in the case group. Moreover, the gene combinations (ABCA4, RDH12) and (ABCA4, RBP3) were identified exclusively in cases of retinal dystrophies. Conclusion: The proposed preliminary model provides a systematic approach to calculate the mutational burden in patients with retinal dystrophies and previous negative genetic test results. Moreover, the bioinformatic analysis facilitated the identification of recurrent combinations of involved genes, suggesting possible new digenic or oligogenic inheritance patterns.

  • Open Access

    Machine Learning–Based Classification of Active and Latent Phases of Inherited Retinal Dystrophies Using Synthetic Proteomic Data: A Pathway-Based Application Exercise

    by Alessandro Macchia, Maria Chiara Medori, Ahmad Jainul Abidin, Gabriele Bonetti, Kristjana Dhuli, Luca Ferrari, Sara Feizyab, Jan Miertuš, Benedetto Falsini, Giorgio Placidi, et al.

    Objectives: Inherited retinal dystrophies are characterized by high genetic and phenotypic heterogeneity, and their clinical progression may alternate between latent and active phases. Identifying the onset of the active phase may support earlier intervention for inflammatory retinal degeneration. Plasma proteomics has shown potential for characterizing predictive biomarkers in retinal diseases, but its application remains experimental. This study aimed to develop a methodological simulation exercise to evaluate the performance of machine learning (ML) models in distinguishing active and latent phases using an artificially generated dataset.Methods: An artificial dataset of 500 samples was created, and plasma proteomic profiles were generated for each sample using arbitrary values. Sample classification was based on a pathway activation score. Four ML models were tested: support vector machine, random forest, logistic regression, and extreme gradient boosting. Each model was trained across a range of hyperparameters.Results: Logistic regression achieved the best performance, with an accuracy of 0.73, precision of 0.73, and F1-score of 0.73.Conclusions: This simulation study showed that synthetic proteomic datasets can be used to evaluate ML approaches for distinguishing active and latent phases of retinal dystrophies when real data are scarce. Synthetic data can support the creation of targeted datasets for proteins associated with retinal dystrophies, helping to address the limited availability of suitable open-source data.